S02722 Summary:

BILL NOS02722
 
SAME ASSAME AS A02970-A
 
SPONSORKLEIN
 
COSPNSRAMEDORE, BROOKS, GALLIVAN, HELMING, KENNEDY, MARCHIONE, MURPHY, O'MARA, ORTT, PHILLIPS, SERINO, VALESKY
 
MLTSPNSR
 
Amd §3302, add §3306-a, Pub Health L; amd §220.00, Pen L
 
Provides that a controlled substance analogue shall be deemed to be the controlled substance to which it is substantially similar or mimics.
Go to top    

S02722 Actions:

BILL NOS02722
 
01/17/2017REFERRED TO HEALTH
03/07/20171ST REPORT CAL.387
03/08/20172ND REPORT CAL.
03/13/2017ADVANCED TO THIRD READING
04/24/2017PASSED SENATE
04/24/2017DELIVERED TO ASSEMBLY
04/24/2017referred to health
01/03/2018died in assembly
01/03/2018returned to senate
01/03/2018REFERRED TO HEALTH
05/31/20181ST REPORT CAL.1486
06/04/20182ND REPORT CAL.
06/05/2018ADVANCED TO THIRD READING
06/20/2018COMMITTED TO RULES
Go to top

S02722 Committee Votes:

Go to top

S02722 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S02722 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          2722
 
                               2017-2018 Regular Sessions
 
                    IN SENATE
 
                                    January 17, 2017
                                       ___________
 
        Introduced  by  Sens. KLEIN, AMEDORE, GALLIVAN, KENNEDY, MURPHY, O'MARA,
          ORTT, SERINO, VALESKY -- read twice  and  ordered  printed,  and  when
          printed to be committed to the Committee on Health
 
        AN  ACT to amend the public health law and the penal law, in relation to
          controlled substance analogues

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section 1.  Section 3302 of the public health law is amended by adding
     2  a new subdivision 44 to read as follows:
     3    44.  "Controlled substance analogue" (a) means a substance, the chemi-
     4  cal structure of which is substantially similar to the  chemical  struc-
     5  ture  of  a  controlled  substance listed in schedule I or II of section
     6  thirty-three hundred six of this title, and which either:
     7    (i) has a  stimulant,  depressant  or  hallucinogenic  effect  on  the
     8  central  nervous system that mimics or is similar to or greater than the
     9  stimulant, depressant or hallucinogenic effect on  the  central  nervous
    10  system  of  a controlled substance listed in schedule I or II of section
    11  thirty-three hundred six of this title; or
    12    (ii) with respect to a particular person, is  a  substance  that  such
    13  person represents or intends to have a stimulant, depressant or halluci-
    14  nogenic effect on the central nervous system that is substantially simi-
    15  lar  to  or  greater  than  the  stimulant, depressant or hallucinogenic
    16  effect on the central nervous system of a controlled substance listed in
    17  schedule I or II of section thirty-three hundred six of this title.
    18    (b) such term shall not include:
    19    (i) a controlled substance;
    20    (ii) any substance for which there is an approved new drug application
    21  by the Federal Food and Drug Administration (FDA); or
    22    (iii) with respect to  a  particular  person,  any  substance,  if  an
    23  exemption  is  in  effect  for  investigational  use for that person, as
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD07432-01-7

        S. 2722                             2
 
     1  provided by 21 U.S.C. § 355, to the extent conduct with respect  to  the
     2  substance is pursuant to such exemption.
     3    §  2.  The public health law is amended by adding a new section 3306-a
     4  to read as follows:
     5    § 3306-a. Controlled substance  analogues.    A  controlled  substance
     6  analogue  shall  be  deemed  to  be,  for  all  purposes,  including all
     7  provisions of law, the controlled substance of which it is an analogue.
     8    § 3. Section 220.00 of the penal law is amended by adding a new subdi-
     9  vision 21 to read as follows:
    10    21. "Knowingly" when used in connection with an offense involving  the
    11  possession  or  sale,  or the attempt or conspiracy to possess or sell a
    12  controlled substance analogue, shall not require knowledge by  a  person
    13  of the chemical structure of the substance, but rather, it is sufficient
    14  if:
    15    (a)  such  person  knew  or  should  have  known  that  the controlled
    16  substance analogue has a stimulant, depressant or hallucinogenic  effect
    17  on the central nervous system that is substantially similar to or great-
    18  er  than  the  stimulant,  depressant  or  hallucinogenic  effect on the
    19  central nervous system of a controlled substance listed in schedule I or
    20  II of section thirty-three hundred six of the public health law; or
    21    (b) such person represented or intended for the substance  to  have  a
    22  stimulant,  depressant  or  hallucinogenic effect on the central nervous
    23  system that is substantially similar to or greater than  the  stimulant,
    24  depressant  or  hallucinogenic effect on the central nervous system of a
    25  controlled substance listed in schedule I or II of section  thirty-three
    26  hundred six of the public health law.
    27    § 4. This act shall take effect immediately.
Go to top